Compass Therapeutics, Inc.
CMPX$1.07B
Small CapNASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaBOSTON35 employees
Drugs in Pipeline
3
Phase 3 Programs
3
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
CMPX News
Catalyst Timeline
0 upcoming, 1 past
No catalysts found.
Drug Pipeline
CTX-009
Metastatic Colorectal Cancer
Paclitaxel
Biliary Tract Cancer
Psilocybin
Post Traumatic Stress Disorder
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
CTX-009 | Phase 3 | Metastatic Colorectal Cancer | - | - |
Paclitaxel | Phase 3 | Biliary Tract Cancer | - | - |
Psilocybin | Phase 3 | Post Traumatic Stress Disorder | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply